Related Experiment Videos
Mortality patterns of the ten leading causes of cardiovascular diseases in Northern Iran: a joinpoint regression
Sara Khaleghi1, Sajad Khodabandelu1, Maryam Nabati2
1Department of Biostatistics and Epidemiology, Student Research Committee, School of Health, Mazandaran University of Medical Sciences, Postal Code, Sari, 48175-866, Iran.
Insights
Cardiovascular disease mortality in northern Iran saw a modest decline over 13 years, with a temporary increase during the COVID-19 pandemic. Prevention efforts should target ischemic heart disease, hypertension, older adults, and men.
Area of Science:
- Public Health
- Epidemiology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading global and Iranian cause of death, especially in northern regions.
- Understanding long-term CVD mortality trends is crucial for public health policy in aging populations.
Purpose of the Study:
- To analyze long-term cardiovascular disease mortality trends in northern Iran from 2011 to 2023.
- To identify specific CVDs, demographic groups, and time periods requiring targeted public health interventions.
Main Methods:
- Population-based retrospective study using mortality data from 2011-2023 in Mazandaran province, Iran.
- Calculated age-standardized mortality rates (ASMR) per 100,000 population using the 2013 European standard.
- Employed Joinpoint regression to analyze mortality trends, calculating annual percent change (APC) and average annual percent change (AAPC).
Main Results:
- Overall ASMR decreased from 173.7 to 167.3 per 100,000 (AAPC: -0.85%).
- A significant decline occurred from 2011-2018, followed by a non-significant increase (2018-2021), and a sharp decline (2021-2023).
- Ischemic heart disease and hypertensive diseases were the leading causes; mortality rates were higher in men.
Conclusions:
- Northern Iran experienced a modest overall decline in CVD mortality, with a notable pandemic-related increase.
- Targeted prevention strategies are needed for ischemic heart disease, hypertensive diseases, older adults, and men.
- Public health policies must adapt to evolving CVD mortality patterns in the region.
Background:
Cardiovascular diseases remain the leading cause of death worldwide and in Iran, particularly in northern regions. Understanding long-term mortality trends is essential for planning effective prevention and health policy strategies in the context of an aging population.
Methods:
A population-based retrospective study was conducted using mortality data from the Health Deputy of Mazandaran University of Medical Sciences and the Civil Registration Organization (2011-2023). All deaths attributed to cardiovascular diseases (ICD-10 codes I00-I99) in Mazandaran province, northern Iran, were included. Age-standardized mortality rates per 100,000 population were calculated using direct standardization to the 2013 European standard population. Trends in mortality were analyzed using Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC) with 95% confidence intervals.
Results:
Between 2011 and 2023, 73,434 cardiovascular deaths were recorded. The overall age-standardized mortality rate decreased from 173.7 to 167.3 per 100,000 (average annual percent change -0.85%;)95% CI -1.96 to -0.65). A significant declining trend was observed from 2011 to 2018 (annual percent change -2.04%; 95% CI -3.59 to -0.45), followed by a temporary non-significant increase between 2018 and 2021 (annual percent change 3.04%; 95% CI -8.57 to 16.13), and a significant sharp decline from 2021 to 2023. Mortality rates were consistently higher in men than women. Ischemic heart disease was the leading specific cause of cardiovascular death throughout the period, followed by hypertensive diseases.
Conclusions:
Cardiovascular mortality in northern Iran showed an overall statistically significant modest decline over the 13-year period, interrupted by a notable increase coinciding with the COVID-19 pandemic years. Targeted prevention efforts should focus on ischemic heart disease, hypertensive diseases, older adults, and men to further reduce the burden of cardiovascular mortality in the region.
Related Concept Videos
Cancer Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Coronary Artery Disease IV: Preventive Measures